Vasculitis in children

Pediatric Clinics of North America

Volumn 52, Issue 2, 2005, Pages 547-575

  Dedeoglu, Fatma ^a,b   Sundel, Robert P ^a,b  

^a BOSTON CHILDREN S HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; AZATHIOPRINE; CORTICOSTEROID; CYCLOPHOSPHAMIDE; ETANERCEPT; IBUPROFEN; IMMUNOGLOBULIN; INFLIXIMAB; METHYLPREDNISOLONE; NEUTROPHIL CYTOPLASMIC ANTIBODY; NONSTEROID ANTIINFLAMMATORY AGENT; PARACETAMOL; PENTOXIFYLLINE; PENTRAXIN; PREDNISOLONE; PREDNISONE; RITUXIMAB; VON WILLEBRAND FACTOR;

ABDOMINAL PAIN; ANAPHYLACTOID PURPURA; ANTIGEN ANTIBODY COMPLEX; ARTHRITIS; BEHCET DISEASE; BLOOD CELL COUNT; CHILD; CHURG STRAUSS SYNDROME; CLINICAL FEATURE; CLINICAL TRIAL; DIFFERENTIAL DIAGNOSIS; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; DISEASE COURSE; DISEASE MARKER; DOSE RESPONSE; DRUG MEGADOSE; EPIDEMIOLOGICAL DATA; FEVER; GASTROINTESTINAL HEMORRHAGE; HUMAN; HUMORAL IMMUNITY; INFLAMMATORY DISEASE; KIDNEY DISEASE; MICROSCOPIC POLYANGIITIS; MUCOCUTANEOUS LYMPH NODE SYNDROME; PATHOGENESIS; PERIODIC FEVER SYNDROME; PHYSICAL EXAMINATION; POLYARTERITIS NODOSA; REVIEW; SIDE EFFECT; SKIN MANIFESTATION; T LYMPHOCYTE; VASCULITIS;

EID: 16244365876     PISSN: 00313955     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pcl.2005.01.006     Document Type: Review

References (105)

1. S.L. Bowyer, C.G. Ragsdale, and D.B. Sullivan Factor VIII related antigen and childhood rheumatic diseases J Rheumatol 16 1989 1093 1097
2. F. Fazzini, G. Peri, and A. Doni PTX3 in small-vessel vasculitides: an independent indicator of disease activity produced at sites of inflammation Arthritis Rheum 44 2001 2841
3. G.S. Hoffman, P.A. Merkel, and R.D. Brasington Anti-tumor necrosis factor therapy in patients with difficult to treat Takayasu arteritis Arthritis Rheum 50 2004 2296
4. Wegener's Granulomatosis Etanercept Trial (WGET) Research Group Etanercept plus standard therapy for Wegener's granulomatosis N Engl J Med 352 2005 351 361
5. K.A. Keogh, M.E. Wylam, J.H. Stone, and U. Specks Induction of remission by B lymphocyte depletion in 11 patients with refractory antineutrophil cytoplasmic antibody-associated vasculitis Arthritis Rheum 52 2005 262 268
6. J.C. Jennette, and R.J. Falk Do vasculitis categorization systems really matter? Curr Rheumatol Rep 2 2000 430
7. V. Tesar, M. Kazderova, and L. Hlavackova Rokitansky and his first description of polyarteritis nodosa J Nephrol 17 2004 172
8. S. Ozen, N. Besbas, and U. Saatci Diagnostic criteria for polyarteritis nodosa in childhood J Pediatr 120 1992 206
9. J.M. Gardner-Medwin, P. Dolezalova, and C. Cummins Incidence of Henoch-Schonlein purpura, Kawasaki disease, and rare vasculitides in children of different ethnic origins Lancet 360 2002 1197
10. S. Bowyer, and P. Roettcher Pediatric rheumatology clinic populations in the United States: results of a 3 year survey. Pediatric Rheumatology Database Research Group J Rheumatol 23 1996 1968
11. D. Huugen, J.W. Tervaert, and P. Heeringa Antineutrophil cytoplasmic autoantibodies and pathophysiology: new insights from animal models Curr Opin Rheumatol 16 2004 4
12. S. Praprotnik, B. Rozman, and M. Blank Pathogenic role of anti-endothelial cell antibodies in systemic vasculitis Wien Klin Wochenschr 112 2000 660
13. S. Yoshinoya [Immune complex and vasculitis] Nippon Rinsho 52 1994 1992 1999 [in Japanese]
14. S. Ozen, J. Anton, and N. Arisoy Juvenile polyarteritis: results of a multicenter survey of 110 children J Pediatr 145 2004 517
15. P.A. Brogan, V. Shah, and A. Bagga T cell Vbeta repertoires in childhood vasculitides Clin Exp Immunol 131 2003 517
16. C.G. Kallenberg, and P. Heeringa Pathogenesis of vasculitis Lupus 7 1998 280
17. J.C. Jennette Implications for pathogenesis of patterns of injury in small- and medium-sized-vessel vasculitis Cleve Clin J Med 69 Suppl 2 2002 SII33
18. R. Blanco, V.M. Martinez-Taboada, and V. Rodriguez-Valverde Henoch-Schonlein purpura in adulthood and childhood: two different expressions of the same syndrome Arthritis Rheum 40 1997 859
19. M. Chaussain, D. De Boisscai, and G. Kalifa Impairment of lung diffusion capacity in HSP J Pediatr 121 1992 12
20. L.D. Dengler, E.V. Capparelli, and J.F. Bastian Cerebrospinal fluid profile in patients with acute Kawasaki disease Pediatr Infect Dis J 17 1998 478
21. R. Coppo, A. Amore, and B. Gianoglio Clinical features of Henoch-Schonlein purpura. Italian Group of Renal Immunopathology Ann Med Interne (Paris) 150 1999 143
22. W.L. Robson, and A.K. Leung Henoch-Schonlein purpura Adv Pediatr 41 1994 163
23. F.T. Saulsbury Henoch-Schonlein purpura in children. Report of 100 patients and review of the literature Medicine (Baltimore) 78 1999 395
24. W.L. Chang, Y.H. Yang, and Y.T. Lin Gastrointestinal manifestations in Henoch-Schonlein purpura: a review of 261 patients Acta Paediatr 93 2004 1427
25. T.S. Gunasekaran, J. Berman, and M. Gonzalez Duodenojejunitis: is it idiopathic or is it Henoch-Schonlein purpura without the purpura? J Pediatr Gastroenterol Nutr 30 2000 22
26. H. Sano, M. Izumida, and H. Shimizu Risk factors of renal involvement and significant proteinuria in Henoch-Schonlein purpura Eur J Pediatr 161 2002 196
27. J. Ronkainen, M. Nuutinen, and O. Koskimies The adult kidney 24 years after childhood Henoch-Schonlein purpura: a retrospective cohort study Lancet 360 2002 666
28. Y. Kawasaki, J. Suzuki, and N. Sakai Clinical and pathological features of children with Henoch-Schoenlein purpura nephritis: risk factors associated with poor prognosis Clin Nephrol 60 2003 153
29. O. Soylemezoglu, O. Ozkaya, and D. Erbas Nitric oxide in Henoch-Schonlein purpura Scand J Rheumatol 31 2002 271
30. D. Muller, D. Greve, and P. Eggert Early tubular proteinuria and the development of nephritis in Henoch-Schonlein purpura Pediatr Nephrol 15 2000 85
31. F. Martino, D. Agolini, and E. Tsalikova Nailfold capillaroscopy in Henoch-Schonlein purpura: a follow-up study of 31 cases J Pediatr 141 2002 145
32. Y. Saraclar, K. Tinaztepe, and G. Adalioglu Acute hemorrhagic edema of infancy (AHEI)-a variant of Henoch-Schonlein purpura or a distinct clinical entity? J Allergy Clin Immunol 86 1990 473
33. L.H. Calabrese, B.A. Michel, and D.A. Bloch The American College of Rheumatology 1990 criteria for the classification of hypersensitivity vasculitis Arthritis Rheum 33 1990 1108
34. R. Sundel, and I. Szer Vasculitis in childhood Rheum Dis Clin North Am 28 2002 625
35. J.T. Flynn, W.E. Smoyer, and T.E. Bunchman Treatment of Henoch-Schonlein purpura glomerulonephritis in children with high-dose corticosteroids plus oral cyclophosphamide Am J Nephrol 21 2001 128
36. J.W. Newburger, M. Takahashi, and J.C. Burns The treatment of Kawasaki syndrome with intravenous gamma globulin N Engl J Med 315 1986 341
37. J.W. Newburger, K.A. Taubert, and S.T. Shulman Summary and abstracts of the Seventh International Kawasaki Disease Symposium: December 4-7, 2001, Hakone, Japan Pediatr Res 53 2003 153
38. J.W. Newburger, M. Takahashi, and M.A. Gerber Diagnosis, treatment, and long-term management of Kawasaki disease: a statement for health professionals from the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association Pediatrics 114 2004 1708
39. A.H. Rowley, S.T. Shulman, and B.T. Spike Oligoclonal IgA response in the vascular wall in acute Kawasaki disease J Immunol 166 2001 1334
40. A.H. Rowley, S.C. Baker, and S.T. Shulman Detection of antigen in bronchial epithelium and macrophages in acute Kawasaki disease by use of synthetic antibody J Infect Dis 190 2004 856
41. H. Yanagawa, M. Yashiro, and Y. Nakamura Nationwide surveillance of Kawasaki disease in Japan, 1984 to 1993 Pediatr Infect Dis J 14 1995 69
42. A.H. Rowley, S.M. Wolinsky, and D.A. Relman Search for highly conserved viral and bacterial nucleic acid sequences corresponding to an etiologic agent of Kawasaki disease Pediatr Res 36 1994 567
43. T. Kawasaki [Acute febrile mucocutaneous syndrome with lymphoid involvement with specific desquamation of the fingers and toes in children] Arerugi 16 1967 178 [in Japanese]
44. J.C. Burns, W.H. Mason, and M.P. Glode Clinical and epidemiologic characteristics of patients referred for evaluation of possible Kawasaki disease. United States Multicenter Kawasaki Disease Study Group J Pediatr 118 1991 680
45. R.P. Sundel Update on the treatment of Kawasaki disease in childhood Curr Rheumatol Rep 4 2002 474
46. D.Y. Leung The potential role of cytokine-mediated vascular endothelial activation in the pathogenesis of Kawasaki disease Acta Paediatr Jpn 33 1991 739
47. L.B. Smith, J.W. Newburger, and J.C. Burns Kawasaki syndrome and the eye Pediatr Infect Dis J 8 1989 116
48. M.M. April, J.C. Burns, and J.W. Newburger Kawasaki disease and cervical adenopathy Arch Otolaryngol Head Neck Surg 115 1989 512
49. A. Joffe, A. Kabani, and T. Jadavji Atypical and complicated Kawasaki disease in infants. Do we need criteria? West J Med 162 1995 322
50. H. Yanagawa, Z. Tuohong, and I. Oki Effects of gamma-globulin on the cardiac sequelae of Kawasaki disease Pediatr Cardiol 20 1999 248
51. J.C. Burns, E.V. Capparelli, and J.A. Brown Intravenous gamma-globulin treatment and retreatment in Kawasaki disease. US/Canadian Kawasaki Syndrome Study Group Pediatr Infect Dis J 17 1998 1144
52. Y.K. Wen, Y. Yang, and C.C. Chang Cerebral vasculitis and intracerebral hemorrhage in Henoch-Schonlein purpura treated with plasmapheresis Pediatr Nephrol 20 2005 223 225
53. R. Yanagihara, and J.K. Todd Acute febrile mucocutaneous lymph node syndrome Am J Dis Child 134 1980 603
54. A.S. Beiser, M. Takahashi, and A.L. Baker A predictive instrument for coronary artery aneurysms in Kawasaki disease. US Multicenter Kawasaki Disease Study Group Am J Cardiol 81 1998 1116
55. S. Kusakawa, and K. Tatara Efficacies and risks of aspirin in the treatment of the Kawasaki disease Prog Clin Biol Res 250 1987 401
56. K. Furusho, T. Kamiya, and H. Nakano High-dose intravenous gammaglobulin for Kawasaki disease Lancet 2 1984 1055
57. K.S. Hsieh, K.P. Weng, and C.C. Lin Treatment of acute Kawasaki disease: aspirin's role in the febrile stage revisited Pediatrics 114 2004 e689
58. H. Kato, S. Koike, and C. Tanaka Coronary heart disease in children with Kawasaki disease Jpn Circ J 43 1979 469
59. M. Shinohara, K. Sone, and T. Tomomasa Corticosteroids in the treatment of the acute phase of Kawasaki disease J Pediatr 135 1999 465
60. Y. Okada, M. Shinohara, and T. Kobayashi Effect of corticosteroids in addition to intravenous gamma globulin therapy on serum cytokine levels in the acute phase of Kawasaki disease in children J Pediatr 143 2003 363
61. R.P. Sundel, A.L. Baker, and D.R. Fulton Corticosteroids in the initial treatment of Kawasaki disease: report of a randomized trial J Pediatr 142 2003 611
62. J.C. Burns, and M.P. Glode Kawasaki syndrome Lancet 364 2004 533
63. J.W. Newburger, M. Takahashi, and A.S. Beiser A single intravenous infusion of gamma globulin as compared with four infusions in the treatment of acute Kawasaki syndrome N Engl J Med 324 1991 1633
64. J.E. Weiss, B.A. Eberhard, and D. Chowdhury Infliximab as a novel therapy for refractory Kawasaki disease J Rheumatol 31 2004 808
65. J. Fukushige, N. Takahashi, and K. Ueda Long-term outcome of coronary abnormalities in patients after Kawasaki disease Pediatr Cardiol 17 1996 71
66. R. Dhillon, P. Clarkson, and A.E. Donald Endothelial dysfunction late after Kawasaki disease Circulation 94 1996 2103
67. M.E. McConnell, D.W. Hannon, and R.D. Steed Fatal obliterative coronary vasculitis in Kawasaki disease J Pediatr 133 1998 259
68. S. Tomita, K. Chung, and M. Mas Peripheral gangrene associated with Kawasaki disease Clin Infect Dis 14 1992 121
69. R.V. Williams, V.M. Wilke, and L.Y. Tani Does abciximab enhance regression of coronary aneurysms resulting from Kawasaki disease? Pediatrics 109 2002 E4
70. Y. Nakamura, H. Yanagawa, and K. Harada Mortality among persons with a history of Kawasaki disease in Japan: the fifth look Arch Pediatr Adolesc Med 156 2002 162
71. A.L. Baker, K. Gauvreau, and J.W. Newburger Physical and psychosocial health in children who have had Kawasaki disease Pediatrics 111 2003 579
72. R. Blanco, V.M. Martinez-Taboada, and V. Rodriguez-Valverde Cutaneous vasculitis in children and adults. Associated diseases and etiologic factors in 303 patients Medicine (Baltimore) 77 1998 403
73. S. Ozen, U. Saatci, and F. Balkanci Familial Mediterranean fever and polyarteritis nodosa Scand J Rheumatol 21 1992 312
74. C.W. Fink Vasculitis Pediatr Clin North Am 33 1986 1203
75. J. David, B.M. Ansell, and P. Woo Polyarteritis nodosa associated with streptococcus Arch Dis Child 69 1993 685
76. A.P. Sheth, J.C. Olson, and N.B. Esterly Cutaneous polyarteritis nodosa of childhood J Am Acad Dermatol 31 1994 561
77. C. Garcia-Porrua, and M.A. Gonzalez-Gay Successful response to infliximab in a patient with undifferentiated spondyloarthropathy coexisting with polyarteritis nodosa-like cutaneous vasculitis Clin Exp Rheumatol 21 2003 S138
78. L. Mouthon, P. Le Toumelin, and M.H. Andre Polyarteritis nodosa and Churg-Strauss angiitis: characteristics and outcome in 38 patients over 65 years Medicine (Baltimore) 81 2002 27
79. P.A. Brogan, and M.J. Dillon Vasculitis from the pediatric perspective Curr Rheumatol Rep 2 2000 411
80. M. Noris Pathogenesis of Takayasu's arteritis J Nephrol 14 2001 506
81. P. Seo, and J.H. Stone Large-vessel vasculitis Arthritis Rheum 51 2004 128
82. A. Kimura, M. Ota, and Y. Katsuyama Mapping of the HLA-linked genes controlling the susceptibility to Takayasu's arteritis Int J Cardiol 75 Suppl 1 2000 S105
83. A. Yalcindag, and R. Sundel Vasculitis in childhood Curr Opin Rheumatol 13 2001 422
84. G.S. Kerr, C.W. Hallahan, and J. Giordano Takayasu arteritis Ann Intern Med 120 1994 919
85. E. Tso, S.D. Flamm, and R.D. White Takayasu arteritis: utility and limitations of magnetic resonance imaging in diagnosis and treatment Arthritis Rheum 46 2002 1634
86. J.W. Seo, I.A. Park, and D.H. Yoon Thoracic aortic aneurysm associated with aortitis-case reports and histological review J Korean Med Sci 6 1991 75
87. L. Calabrese Primary angiitis of the central nervous system: the penumbra of vasculitis J Rheumatol 28 2001 465
88. K.T. Gallagher, B. Shaham, and A. Reiff Primary angiitis of the central nervous system in children: 5 cases J Rheumatol 28 2001 616
89. S. Benseler, and R. Schneider Central nervous system vasculitis in children Curr Opin Rheumatol 16 2004 43
90. M. Rottem, A.S. Fauci, and C.W. Hallahan Wegener granulomatosis in children and adolescents: clinical presentation and outcome J Pediatr 122 1993 26
91. C.A. Langford, M.C. Sneller, and C.W. Hallahan Clinical features and therapeutic management of subglottic stenosis in patients with Wegener's granulomatosis Arthritis Rheum 39 1996 1754
92. F. Yu, M.H. Zhao, and J.P. Huang [Clinical and pathological features of anti-neutrophil cytoplasm antibody associated systemic vasculitis in children] Zhonghua Er Ke Za Zhi 41 2003 831 [in Japanese]
93. C.A. Langford, and M.C. Sneller Update on the diagnosis and treatment of Wegener's granulomatosis Adv Intern Med 46 2001 177
94. C.A. Langford, C. Talar-Williams, and K.S. Barron A staged approach to the treatment of Wegener's granulomatosis: induction of remission with glucocorticoids and daily cyclophosphamide switching to methotrexate for remission maintenance Arthritis Rheum 42 1999 2666
95. P. Heeringa, and J.W. Tervaert Pathophysiology of ANCA-associated vasculitides: are ANCA really pathogenic? Kidney Int 65 2004 1564
96. J.S. Sanders, M.C. Slot, and C.A. Stegeman Maintenance therapy for vasculitis associated with antineutrophil cytoplasmic autoantibodies N Engl J Med 349 2003 2072
97. C.M. Weyand, and J.J. Goronzy Medium- and large-vessel vasculitis N Engl J Med 349 2003 160
98. B. Eldem, C. Onur, and S. Ozen Clinical features of pediatric Behcet's disease J Pediatr Ophthalmol Strabismus 35 1998 159
99. Y. Uziel, R. Brik, and S. Padeh Juvenile Behcet's disease in Israel. The Pediatric Rheumatology Study Group of Israel Clin Exp Rheumatol 16 1998 502
100. S.H. Park, K.S. Park, and Y.I. Seo Association of MICA polymorphism with HLA-B51 and disease severity in Korean patients with Behcet's disease J Korean Med Sci 17 2002 366
101. T. Sakane, and M. Takeno Current therapy in Behcet's disease Skin Therapy Lett 5 2000 3
102. S. Ozen Vasculopathy, Behcet's syndrome, and familial Mediterranean fever Curr Opin Rheumatol 11 1999 393
103. P. Lamprecht, F. Moosig, and S. Adam-Klages Small vessel vasculitis and relapsing panniculitis in tumour necrosis factor receptor associated periodic syndrome (TRAPS) Ann Rheum Dis 63 2004 1518
104. G.G. Hunder, and A.P. Wilking Classification of the vasculitides in children. UptoDate, 2005 Available at: http://www.utdol.com/application/search. asp Accessed February 14, 2005
105. Centers for Disease Control Revised diagnostic criteria for Kawasaki disease MMWR 39 No. 44-13 1990 27 28